National Institute on Aging; Notice of Closed Meeting, 40776 [2017-18199]
Download as PDF
40776
Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices
Competitive Advantages
• This invention comprises a method
of treating HIV using therapeutics
geared toward viral release and entry,
distinguishing it from other antiviral
candidates with its method of action.
• CD62L is a new target for HIV
Development Stage
• In vitro studies; Proof-of-concept
studies.
Inventors
Peter Sun, NIAID, NIH
Joseph Kononchik, NIAID, NIH
Joanna Ireland, NIAID, NIH
Ruiping Wang, NIAID, NIH
Intellectual Property: HHS Reference
No. E–261–2015/0—PCT No. PCT/
US2016/068713 filed 12/27/2016.
Licensing Contact: Chris Kornak, 240–
627–3705, Chris.Kornak@nih.gov.
Collaborative Research Opportunity:
The Technology Transfer and
Intellectual Property Office (TTIPO) is
seeking parties interested in
collaborative research to further codevelop this technology by identifying
pharmacological compounds inhibiting
CD62L shedding by using high
throughput compound screening. For
collaboration opportunities, please
contact Chris Kornak, 240–627–3705,
Chris.Kornak@nih.gov.
Dated: August 15, 2017.
Suzanne Frisbie,
Deputy Director, Technology Transfer and
Intellectual Property Office, National Institute
of Allergy and Infectious Diseases.
[FR Doc. 2017–18137 Filed 8–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Office of the Director; Notice of Charter
Renewal
It is determined that the Advisory
Committee to the Deputy Director for
Intramural Research, National Institutes
of Health, is in the public interest in
connection with the performance of
duties imposed on the National
Institutes of Health by law, and that
these duties can best be performed
through the advice and counsel of this
group.
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the Advisory
Committee to the Deputy Director for
Intramural Research, National Institutes
of Health, was renewed for an
VerDate Sep<11>2014
18:45 Aug 25, 2017
Jkt 241001
additional two-year period on August
15, 2017.
Inquiries may be directed to Jennifer
Spaeth, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or spaethj@od.nih.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: August 18, 2017.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
AGENCY:
[FR Doc. 2017–18197 Filed 8–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group; Behavior and
Social Science of Aging Review Committee.
Date: October 5–6, 2017.
Time: 3:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Kimberly Firth, Ph.D.,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–402–7702,
kimberly.firth@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 23, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–18199 Filed 8–25–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
National Institutes of Health
Proposed Collection: 60-Day Comment
Request; Generic Clearance To
Support the Safe to Sleep® Campaign
at the Eunice Kennedy Shriver National
Institute for Child Health and Human
Development (NICHD)
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development (NICHD), the National
Institutes of Health (NIH) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Lorena Kaplan, M.P.H., CHES,
Office of Communications, Eunice
Kennedy Shriver National Institute of
Child Health and Human Development,
National Institutes of Health, 31 Center
Drive, Room 2A32, Bethesda, Maryland
20892, or call non-toll free number (301)
496–6670 or Email your request,
including your address to
lorena.kaplan@nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
ways to enhance the quality, utility, and
clarity of the information to be
SUMMARY:
E:\FR\FM\28AUN1.SGM
28AUN1
Agencies
[Federal Register Volume 82, Number 165 (Monday, August 28, 2017)]
[Notices]
[Page 40776]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18199]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Initial Review
Group; Behavior and Social Science of Aging Review Committee.
Date: October 5-6, 2017.
Time: 3:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Kimberly Firth, Ph.D., National Institute on
Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212,
Bethesda, MD 20892, 301-402-7702, kimberly.firth@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: August 23, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-18199 Filed 8-25-17; 8:45 am]
BILLING CODE 4140-01-P